We here assessed signaling functions of TIMP-3 in vitro and in vivo within the context of DR and on the basis of these findings, we hypothesized that enhancing the expression of TIMP-3 could serve as a potential therapeutic strategy for the amelioration of diabetes-induced retinal injury. This evidence concerns the gene TIMP3 and diabetes mellitus.